ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

DCPC Advisors Upset At NCAB Over Why Decision, But Move On

February 8, 1991

Funding Opportunities: RFAs Available: NCI Challenge For Tumor Classification

February 5, 1999

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980